Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared to Competitors

Dow Jones
08/19

DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ shed 3.91% to $10.08 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.33% to 26,289.71 and Dow Jones Industrial Average falling 0.22% to 53,343.40.

The stock's fall snapped a five-day winning streak.

Corbus Pharmaceuticals Holdings Inc. closed 50.97% short of its 52-week high of $20.56, which the company reached on October 20th.

The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ rose 3.42% to $5.44, Fortress Biotech Inc. (FBIO) rose 3.19% to $2.91, and Viking Therapeutics Inc. (VKTX) fell 0.77% to $33.37.

Trading volume (329,116) remained 54,139 below its 50-day average volume of 383,255.

Data source: Dow Jones Market Data, FactSet. Data compiled August 18, 2026.

 

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10